1380244-48-3

Upstream product

• 474333-63-6 (2R,4S,5R)-4-isopropyl-2-(4-methoxyphenyl)-5-methyl-1,3-dioxane 
• 3876-46-8 (2R,3S)-2,4-dimethyl-1,3-pentane diol 
• 2186-92-7 p-Anisaldehyde dimethyl acetal 

Downstream Products

• 1380244-49-4 (2R,4S,5S,6R,7S)-5-hydroxy-7-(4-methoxybenzyloxy)-4,6,8-trimethyl-3-oxononan-2-yl benzoate 
• 1380244-59-6 (2R,4S)-4-((4S,5S,6S)-6-isopropyl-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl)-3-oxopentan-2-yl benzoate 
• 1380244-50-7 (2R,4S,5S,6S,7S)-7-((4-methoxybenzyl)oxy)-4,6,8-trimethyl-3-oxo-5-((triethylsilyl)oxy)nonan-2-yl benzoate 
• 1380244-51-8 (4S,5S,6S,7S)-7-((4-methoxybenzyl)oxy)-4,6,8-trimethyl-5-((triethylsilyl)oxy)nonan-3-one 
• 1380244-52-9 (2S,3S,4R,6S,7S,8S,9S)-2-((2S,4S,5R,6S)-6-ethyl-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl)-3-hydroxy-9-((4-methoxybenzyl)oxy)-4,6,8,10-tetramethyl-7-((triethylsilyl)oxy)undecan-5-one 
• 1380244-53-0 (2R,4R,6S,7S,8S,9S)-2-((2S,4R,5R,6S)-6-ethyl-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl)-9-((4-methoxybenzyl)oxy)-4,6,8,10-tetramethyl-7-((triethylsilyl)oxy)undecane-3,5-dione 
• 1380244-54-1 (R)-(3S,4S,5S,6S)-3-((4-methoxybenzyl)oxy)-2,4,6-trimethyl-7-oxononan-5-yl 2-((2S,4R,5R,6S)-6-ethyl-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl)propanoate 
• 1380244-55-2 (2R,3R,4R,5S)-(3S,4S,5S,6S)-3-((4-methoxybenzyl)oxy)-2,4,6-trimethyl-7-oxononan-5-yl 3,5-dihydroxy-2,4-dimethylheptanoate 
• 1380244-56-3 (2R,3R,4S)-(3S,4S,5S,6S)-3-((4-methoxybenzyl)oxy)-2,4,6-trimethyl-7-oxononan-5-yl 3-hydroxy-2,4-dimethyl-5-oxoheptanoate 

Relevant academic research and scientific papers

In silico inspired total synthesis of (-)-dolabriferol

Going retro: The diazabicycloundecane-induced retro-Claisen rearrangement of a linear precursor serves as the key step to form the hindered ester of the polypropionate dolabriferol (1, see scheme, PMB=p-methoxybenzyl, PMP=p-methoxyphenyl, TES=triethylsilyl). The rearrangement is thought to mimic the biosynthetic formation of 1. Copyright